Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours

By van Moorsel C.J.A.   Pinedo H.M.   Smid K.   Comijn E.M.   Voorn D.A.   Veerman G.   Lakerveld B.   Van der Vijgh W.J.F.   Giaccone G.   Postmus P.E.   Peters G.J.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2420-2429

Elsevier

Access to resources Recommend Favorite

Efficacy of Intra-arterial Infusion Therapy Using a Combination of Cisplatin and Docetaxel for Recurrent Head and Neck Cancers Compared with Cisplatin Alone

By Yabuuchi H.   Kuroiwa T.   Tajima T.   Tomita K.   Ochiai N.   Kawamoto K.  

Clinical Oncology, Vol. 15, Iss. 8, 2003-12 ,pp. : 467-472

Elsevier

Access to resources Recommend Favorite

Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer: A retrospective analysis of 519 patients: A single institution experience

By Pai V.   Mazumdar A.   Deshmukh C.   Bakshi A.   Parikh D.   Parikh P.   Mistry R.   Pathak K.  

Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. : 1-5

Humana Press, Inc

Access to resources Recommend Favorite

Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer - A randomised phase II EORTC trial

By Bartelink H.   Van den Bogaert W.   Horiot J.-C.   Jager J.   van Glabbeke M.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 667-673

Elsevier

Access to resources Recommend Favorite

Schedule-dependent Antagonism of Paclitaxel and Cisplatin in Human Gastric and Ovarian Carcinoma Cell Lines In Vitro

By Vanhoefer U.   Harstrick A.   Wilke H.   Schleucher N.   Walles H.   Schroder J.   Seeber S.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 92-97

Elsevier

Access to resources Recommend Favorite